CClinicalTrials.gg
Sign In
CompletedNCT02471261Updated Oct 23, 2020

Elastography as Gouty Arthropathy Outcome (EGO)

An observational study in Gout, sponsored by Arthritis & Rheumatism Associates, P.C.. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-10-23.

Sponsored by Arthritis & Rheumatism Associates, P.C. · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
10
Ages
18 Years and older
Sex
All
01

Study summary

Elastography as Gouty Arthropathy Outcome (EGO), a pilot study.

Read the detailed description

Pilot study to assess 10 subjects with tophaceous gout on urate lowering therapy or about to begin urate lowering therapy.

02

Conditions studied

  • Gout

Browse trials for

03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's enrollment of 10 is below the median of 100 across 216 observational studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Arthritis & Rheumatism Associates, P.C. is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A pilot study to assess 10 subjects with tophaceous gout on urate lowering therapy or about to begin urate lowering therapy.

Inclusion criteria

  1. Subjects who are at least 18 years of age but younger than or equal to 99 years of age.
  2. Subjects with gouty arthritis as determined by the ACR 1977 classification criteria for gouty arthritis.
  3. Subjects with one palpable tophus detectable by one of the three clinical parameters described.

Exclusion criteria

-

Exclusion Criteria:

  1. Subjects who are not eligible for urate lowering treatment or show a hypersensitivity to these drugs or class of compounds.
  2. Subjects with significant cardiovascular, neuropsychiatric, hematologic, hepatic, renal or endocrine dysfunction who in the opinion of the principal investigator are unfit for participation in a clinical trial.

  3. Subjects for which the clinical and laboratory assessment would provide undue discomfort and / or are contraindicated.

    -

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Elastography as Gouty Arthropathy Outcome (EGO), a pilot study

    Observational trial to measure gouty arthritis changes in subject taking urate lowering therapies

    Time frame: 1 year

07

Study locations

1 site
  • The Center for Rheumatology and Bone Research
    Wheaton, Maryland 20902, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02471261
Lead sponsor
Arthritis & Rheumatism Associates, P.C.
Responsible party
Sponsor
First posted
Jun 15, 2015
Start date
May 2015
Primary completion
Dec 2016
Completion
Mar 2017
Last update
Oct 23, 2020

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Joint Diseases→

Other studies from this sponsor

Arthritis & Rheumatism Associates, P.C.

Start the discussion